Taken together, these results demonstrate that pterostilbene treatment inhibits tumor cell proliferation and angiogenesis and induces apoptosis in Pten-loss prostate tumors, at least in part, due to inhibition of MTA1. The gene discussed is PTEN; the disease is prostate neoplasm.